Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer

Clinical trial NCT06421376 · RECRUITING

Trial details

NCT number: NCT06421376
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer Immunotherapy Induction Therapy Chemoradiotherapy Surgery

Start date: 2024-05-01
Primary completion: 2026-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.